One specialist investor just walked away from STAAR Surgical entirely—right as uncertainty over a delayed Alcon deal looms.Palo Alto Investors fully exited its position in STAAR Surgical Company (STAA +1.74%), reducing its stake by 791,879 shares in the third quarter, a net change of approximately $13.3 million, according to a November 14 SEC filing.What HappenedPalo Alto Investors disclosed in a November 1, SEC filing that it sold out of STAAR Surgical Company during the third quarter. The fund reported a ...